Debt-to-Equity

NW Natural Holdings just secured its 71st year of dividend hikes. A forensic look at how Texas gas and water acquisitions are fueling the historic payout.

Neogen's Q1 results show promise with raised guidance, but debt, transition costs, and a new FDA warning reveal a steep climb ahead for the company.

Vaxcyte is arming itself with $1 billion in fresh capital to challenge Pfizer and Merck, leveraging a dual-tranche financing strategy to scale manufacturing.

A $6.1 billion biorefinery in Uzbekistan unites Chinese, American, and European engineering titans to test the massive scale of green aviation fuel.

As Iron Mountain executives prepare for key tech conferences, they aren't just presenting financials; they're selling a new identity as a data infrastructure leader.

CrossCountry Mortgage just spent $1.28 billion to control your loan from start to finish. Is this a new industry blueprint or a debt-fueled risk for homeowners?

TerraVest doubles down on its own stock with a massive buyback, calling it undervalued. But with rising debt and an aggressive M&A strategy, is this a shrewd move or a risky bet?

DCW Limited is pouring ₹250 crore into its pigment business, aiming to boost capacity by 50% and capture a growing global market. This isn't just expansion; it's a calculated move to secure a more profitable future.

With a blockbuster IPO and dazzling growth, Bending Spoons looks unstoppable. But a closer look reveals a high-stakes strategy built on massive debt.

Once burdened by debt, Battalion Oil's aggressive financial overhaul and laser focus on its Monument Draw asset signal a dramatic corporate resurrection.

Amidst high inflation and cautious spending, Assaí not only grew but fortified its finances. Here’s the why behind its masterclass in operational grit.

Eutelsat's pivot to LEO connectivity is fueling impressive growth, yet high costs and margin pressures have investors wary. Is this the cost of becoming Europe's sovereign space champion?

Morgan Stanley's lending arm maintains its dividend, but rising non-accruals and a NAV dip reveal the defensive maneuvers required in a cooling credit market.

Q2 results show growth, but rising costs and heavy spending underscore the pressure on Granite Ridge to hit its 2027 free cash flow inflection point.

Fox Corp. posts record earnings fueled by the World Cup, but the real story is its massive $22B bet on Roku to conquer the future of television streaming.

BKV Corp. is building a new energy model, using robust gas profits to fund an ambitious expansion into power generation and carbon capture technology.

GPGI's Q2 results show a tale of two subsidiaries. While fintech darling CompoSecure hits records, industrial giant Husky faces market drag. Can one system steer both?

Evolent Health touts soaring revenues and a major oncology deal, yet falling profits and rising medical costs reveal a challenging road ahead. Can AI deliver the efficiency it needs?

Permian Resources promises stability with a new dividend, but can its financial discipline withstand falling oil prices and a volatile market?

OCSL reports a slight income dip but showcases robust health with a stable NAV, a sharp drop in non-accruals, and consistent shareholder distributions.